ArticleMolecular neurobiology2026
Unraveling Hippocampal and Prefrontal Cortex Alterations in Experimental Type 1 and Type 2 Diabetes: A 100-Day Exploration of Biochemical and Behavioral-Cognitive Dysfunction.
Article in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite increasing evidence, the specific long-term effects of type 1 diabetes (T1D) and type 2 diabetes (T2D) on the functions of the hippocampus and prefrontal cortex (PFC) remain poorly understood. This study aimed to provide a comprehensive comparison of the chronic neurobiological, cognitive, and behavioral consequences of prolonged hyperglycemia in experimental models of T1D and T2D. By combining behavioral assessments with biochemical and neurochemical analyses, the study sought to identify diabetes type-specific patterns of dysfunction within the hippocampus and PFC. Adult rats were randomly assigned to three groups: Sham, T1D, and T2D. T1D was induced by a single intraperitoneal injection of streptozotocin (STZ), while T2D was established by administering nicotinamide (NA) 15 min prior to STZ injection. Behavioral assessments and Cognitive functions were conducted during the final phase of the experimental period. Following behavioral testing, blood samples were collected for biochemical analyses. The PFC and hippocampus were dissected for evaluation of oxidative stress markers, inflammatory mediators, acetylcholinesterase (AChE) activity, BDNF levels, and Na⁺/K⁺-ATPase activity. Additionally, a histological examination of these brain regions was performed to assess neuronal integrity using Nissl staining. After 100 days of hyperglycemia, both T1D and T2D rats exhibited significant functional and structural alterations in the hippocampus and PFC. T2D was significantly associated with pronounced oxidative stress and inflammatory responses, related with anxiety- and depression-like behaviors (P < 0.05). In contrast, T1D induced more extensive cognitive decline, neurochemical and structural disruption, including marked BDNF depletion, significant Na⁺/K⁺-ATPase reduction, and elevated AChE activity (P < 0.05), suggesting greater neuronal stress and degeneration compared to T2D. These findings highlight diabetic encephalopathy as a multifactorial disorder involving concurrent impairments in neurotrophic support, metabolic regulation, and neurotransmitter balance, with T2D characterized by greater oxidative stress and inflammation, and T1D exhibiting more severe neurochemical and structural damage.
Indexed as
Identifiers
42430106What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.